Delivery Order SPE2DB22D2007-SPE2DB25FJ5CL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,257.16 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription migraine treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $11,213.10 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $34,819.18 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $54,649.34 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine,...
- The Defense Logistics Agency awarded a delivery order valued at $29,747.53 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on March 5, 2025, with completion scheduled for March 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,427.02 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication used to manage acute migraine episodes,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $48,497.72 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $5,362.99. This firm fixed price delivery order, which is due for completion by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order valued at $25,858.83 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical distributor's role in...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5CLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $187,109.28 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 18, 2025, with completion expected by September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical products supplied under this contract vehicle. This delivery order represents a child action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical and medical supply solutions to military healthcare systems and other government agencies through this prime indefinite delivery vehicle, which supports global pharmaceutical needs across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $187.1k | 9/18/25 |